RELEVANCE OF BIOCHEMICAL TUMOR-MARKERS AND LYMPHADENECTOMY IN MANAGEMENT OF NON-SEMINOMATOUS TESTIS TUMORS - CURRENT PERSPECTIVE

被引：79

作者：

SKINNER, DG ^{[1
]}

SCARDINO, PT ^{[1
]}

机构：

[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT SURG UROL,LOS ANGELES,CA 90024

来源：

关键词：

D O I：

10.1016/S0022-5347(17)55944-3

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：378 / 382

页数：5

共 19 条

[1]

DONOHUE JP, 1978, CANCER-AM CANCER SOC, V42, P2903, DOI 10.1002/1097-0142(197812)42:6<2903::AID-CNCR2820420653>3.0.CO

[2]

2-K

[3] IMPROVED CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER [J].

EINHORN, LH ;

DONOHUE, JP .

KASWICK, JA ;

BLOOMBERG, SD ;

SKINNER, DG .

[5]

KURMAN RJ, 1977, CANCER-AM CANCER SOC, V40, P2136, DOI 10.1002/1097-0142(197711)40:5<2136::AID-CNCR2820400524>3.0.CO

[6]

2-D

[7]

MACKENZIE AR, 1966, CANCER-AM CANCER SOC, V19, P1369, DOI 10.1002/1097-0142(196610)19:10<1369::AID-CNCR2820191006>3.0.CO

[8]

2-M

[9]

SAMUELS ML, 1975, CANCER, V36, P318, DOI 10.1002/1097-0142(197508)36:2<318::AID-CNCR2820360205>3.0.CO

[10]

2-V